ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 663

$651K Total Retail Price of All Prescriptions

Rank: 31 out of 663

479 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

22% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 6,644 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
HYDROCODONE-ACETAMINOPHEN 607 412 S3 1 6
LISINOPRIL 411 326 2 2
LEVOTHYROXINE SODIUM 357 306 3 3
AMLODIPINE BESYLATE 317 236 4 5
METFORMIN HCL ER 245 185 5 90
ATORVASTATIN CALCIUM 221 176 6 13
OMEPRAZOLE 209 141 7 4
SIMVASTATIN 165 138 8 1
FUROSEMIDE 159 127 9 7
ZOLPIDEM TARTRATE 151 125 10 16
POTASSIUM CHLORIDE 150 136 11 23
RANITIDINE HCL 146 101 12 31
HYDROCHLOROTHIAZIDE 133 111 13 12
GABAPENTIN 115 78 14 20
JANUVIA 114 109 15 78
PRAVASTATIN SODIUM 105 101 16 21
OXYCODONE-ACETAMINOPHEN 104 65 S2 17 26
METFORMIN HCL 97 90 18 9
NEXIUM 93 70 19 43
METOPROLOL TARTRATE 89 54 20 11
AMITRIPTYLINE HCL 88 49 R 21 95
OXYCODONE HCL-ACETAMINOPHEN 84 59 S2 22 128
CYCLOBENZAPRINE HCL 81 44 R 23 71
SERTRALINE HCL 81 64 23 35
WARFARIN SODIUM 80 71 25 8
ACTOS 79 71 26 105
ALENDRONATE SODIUM 79 74 26 15
BYETTA 75 46 28 279
DIOVAN 75 67 28 59
OXYCODONE HCL 73 25 S2 30 41
PAROXETINE HCL 72 43 31 68
CRESTOR 72 52 31 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 70 61 33 242
TRAMADOL HCL 69 49 34 17
ADVAIR DISKUS 69 52 34 53
COMBIVENT 64 49 36 125
ATENOLOL 64 47 36 10
FLUOXETINE HCL 59 26 38 32
PHENYTOIN SODIUM EXTENDED 59 46 38 167
CLONIDINE HCL 59 46 38 79
IBUPROFEN 57 27 41 89
SPIRIVA 56 55 42 62
EVISTA 54 54 43 150
METOPROLOL SUCCINATE 53 49 44 25
ALLOPURINOL 51 35 45 28
TRIAMCINOLONE ACETONIDE 51 41 45 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.